skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
BCR-ABL Peptide Vaccine (Code C2205)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: BCR-ABL Peptide Vaccine

Definition: A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. (NCI04)

Label: BCR-ABL Peptide Vaccine

NCI Thesaurus Code: C2205 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0879331  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
BCR-ABL Peptide Vaccine
bcr-abl vaccine

External Source Codes: 
PDQ Closed Trial Search ID 43623
PDQ Open Trial Search ID 43623 (check for NCI PDQ open clinical trial info)
UMLS CUI C0879331

Other Properties:
     Name Value (qualifiers indented underneath)
code C2205
Legacy_Concept_Name BCR-ABL_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom